Breaking News
Get 40% Off 0
🔎 See NVDA full ProTips for an instant risks or rewards Claim 40% OFF
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
94.51 +6.92    +7.90%
16:36:21 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 3,318,453
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 91.06 - 96.31
Moderna 94.51 +6.92 +7.90%

MRNA Balance Sheet

 
Featured here, the Balance Sheet for Moderna Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
30/09
2023
30/06
2023
31/03
2022
31/12
Total Current Assets 10799 10599 12122 13431
Cash and Short Term Investments 7573 8459 8923 9902
Cash - - - -
Cash & Equivalents 2932 3801 3441 3205
Short Term Investments 4641 4658 5482 6697
Total Receivables, Net 2146 647 1521 1664
Accounts Receivables - Trade, Net 1866 232 1113 1385
Total Inventory 548 776 951 1168
Prepaid Expenses 187 332 292 216
Other Current Assets, Total 345 385 435 481
Total Assets 19450 21884 24125 25858
Property/Plant/Equipment, Total - Net 2717 2410 2135 2139
Property/Plant/Equipment, Total - Gross 3789 3236 2871 2797
Accumulated Depreciation, Total -1072 -826 -736 -658
Goodwill, Net 52 52 52 -
Intangibles, Net 45 46 48 -
Long Term Investments 5359 6224 7525 8360
Note Receivable - Long Term 280 415 408 243
Other Long Term Assets, Total 478 1073 981 946
Other Assets, Total 3388 6652 6609 7700
Total Current Liabilities 4385 3123 3499 4923
Accounts Payable 494 310 389 487
Payable/Accrued - - - -
Accrued Expenses 2018 1200 1335 1833
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 183 221 181 196
Other Current liabilities, Total 1690 1392 1594 2407
Total Liabilities 5995 4935 5262 6735
Total Long Term Debt 575 843 831 912
Long Term Debt - - - -
Capital Lease Obligations 575 843 831 912
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 1035 969 932 900
Total Equity 13455 16949 18863 19123
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - - - -
Additional Paid-In Capital 277 193 731 1173
Retained Earnings (Accumulated Deficit) 13389 17019 18399 18320
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -211 -263 -267 -370
Total Liabilities & Shareholders' Equity 19450 21884 24125 25858
Total Common Shares Outstanding 381 381 384 385
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email